[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2014049566A3 - Kit nutritionnel - Google Patents

Kit nutritionnel Download PDF

Info

Publication number
WO2014049566A3
WO2014049566A3 PCT/IB2013/058945 IB2013058945W WO2014049566A3 WO 2014049566 A3 WO2014049566 A3 WO 2014049566A3 IB 2013058945 W IB2013058945 W IB 2013058945W WO 2014049566 A3 WO2014049566 A3 WO 2014049566A3
Authority
WO
WIPO (PCT)
Prior art keywords
nutritional supplements
kit
nutritional
demise
myelin
Prior art date
Application number
PCT/IB2013/058945
Other languages
English (en)
Other versions
WO2014049566A2 (fr
Inventor
Susan Janse Van Rensburg
Winston BURSEY
Frans Johannes Cronje
Theresa JANSE VAN RENSBURG
Original Assignee
Stellenbosch University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stellenbosch University filed Critical Stellenbosch University
Publication of WO2014049566A2 publication Critical patent/WO2014049566A2/fr
Publication of WO2014049566A3 publication Critical patent/WO2014049566A3/fr
Priority to ZA2015/02635A priority Critical patent/ZA201502635B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

L'invention divulgue un kit à utiliser dans un procédé visant à empêcher l'endommagement ou la mort de cellules produisant de la myéline. Le procédé comprend l'administration à un patient nécessitant un tel traitement d'une quantité efficace d'une pluralité de suppléments nutritionnels. Le kit comprend un récipient comprenant une pluralité de compartiments distincts, chaque compartiment contenant une pluralité d'unités de dosage des suppléments nutritionnels, tels que des minéraux, des vitamines, des acides aminés essentiels et du fer. Les suppléments nutritionnels constituent des doses multi-unités quotidiennes suffisantes pour une période de temps.
PCT/IB2013/058945 2012-09-28 2013-09-27 Kit nutritionnel WO2014049566A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA2015/02635A ZA201502635B (en) 2012-09-28 2015-04-20 Nutritional kit

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA201207347 2012-09-28
ZA2012/07347 2012-09-28

Publications (2)

Publication Number Publication Date
WO2014049566A2 WO2014049566A2 (fr) 2014-04-03
WO2014049566A3 true WO2014049566A3 (fr) 2014-09-12

Family

ID=49765593

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2013/058945 WO2014049566A2 (fr) 2012-09-28 2013-09-27 Kit nutritionnel

Country Status (2)

Country Link
WO (1) WO2014049566A2 (fr)
ZA (1) ZA201502635B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12042477B2 (en) 2016-02-23 2024-07-23 Cancer Research Technology Limited Dietary product devoid of at least two non essential amino acids
IT201800005508A1 (it) * 2018-05-18 2019-11-18 Kit per uso come integratore alimentare nel trattamento delle carenze di vitamine e/o minerali in ambito pediatrico.
IT201900025069A1 (it) * 2019-12-20 2021-06-20 Alidans S R L Composizione orale per promuovere la rigenerazione di nervi periferici
JP2023528930A (ja) 2020-06-04 2023-07-06 フェス・セラピューティクス，インコーポレーテッド がんを処置する個別化された方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050136106A1 (en) * 2000-11-20 2005-06-23 Adrian Sandler Therapeutic placebo enhancement of commonly used medications
US20050256028A1 (en) * 2004-05-13 2005-11-17 Yun Anthony J Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase
WO2008073851A2 (fr) * 2006-12-08 2008-06-19 Massachusetts Institute Of Technology Libération déclenchée à distance depuis des surfaces pouvant être chauffées
WO2009025617A1 (fr) * 2007-08-23 2009-02-26 Astrazeneca Ab Nouvelle combinaison 937
WO2010001186A1 (fr) * 2008-07-04 2010-01-07 Pécsi Tudományegyetem Composé d'acitvation d'une combinaison d'inhibiteur parp de d'une akt kinase
WO2010117848A1 (fr) * 2009-03-31 2010-10-14 East Carolina University Cytokines et neuroantigènes utilisés dans le traitement de maladies immunitaires
WO2012129305A1 (fr) * 2011-03-23 2012-09-27 Pop Test Cortisol Llc Polythérapie

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050136106A1 (en) * 2000-11-20 2005-06-23 Adrian Sandler Therapeutic placebo enhancement of commonly used medications
US20050256028A1 (en) * 2004-05-13 2005-11-17 Yun Anthony J Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase
WO2008073851A2 (fr) * 2006-12-08 2008-06-19 Massachusetts Institute Of Technology Libération déclenchée à distance depuis des surfaces pouvant être chauffées
WO2009025617A1 (fr) * 2007-08-23 2009-02-26 Astrazeneca Ab Nouvelle combinaison 937
WO2010001186A1 (fr) * 2008-07-04 2010-01-07 Pécsi Tudományegyetem Composé d'acitvation d'une combinaison d'inhibiteur parp de d'une akt kinase
WO2010117848A1 (fr) * 2009-03-31 2010-10-14 East Carolina University Cytokines et neuroantigènes utilisés dans le traitement de maladies immunitaires
WO2012129305A1 (fr) * 2011-03-23 2012-09-27 Pop Test Cortisol Llc Polythérapie

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VAN RENSBURG S J ET AL: "Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis", METABOLIC BRAIN DISEASE, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 21, no. 2-3, 26 May 2006 (2006-05-26), pages 117 - 133, XP019452594, ISSN: 1573-7365, DOI: 10.1007/S11011-006-9019-0 *

Also Published As

Publication number Publication date
WO2014049566A2 (fr) 2014-04-03
ZA201502635B (en) 2016-06-29

Similar Documents

Publication Publication Date Title
WO2016190683A8 (fr) Composition pour la prévention et le traitement de maladies musculaires ou l'amélioration de la fonction musculaire, contenant un extrait de platycodon grandiflorum
GB2502032A (en) Vitamin D composition
IN2014DN08215A (fr)
WO2014049566A3 (fr) Kit nutritionnel
GB2492680A (en) Oral supplement
MX2016016995A (es) Composiciones de acido fitico, magnesio y polifenoles y su aplicacion para la prevencion de la litiasis renal oxalocalcica.
MY171048A (en) Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions
TN2016000121A1 (en) Cyclic thienouracil-carboxamides and use thereof
WO2011019735A3 (fr) Compléments nutritionnels
PH12015501561A1 (en) Method of treatment of diseases
MX2013006741A (es) Composicones a base de arcilla y polen de abeja, su proceso de preparacion y su uso nutricional y terapeutico.
GB2521979A (en) A method, use, and dietary supplement composition for at least treating an atopic or non-atopic disorder in a patient
GB201307973D0 (en) Extracts of cynanchum SP.and active ingredients contained therein in use of arthritis treatment
MX2022013541A (es) Composiciones de acido gamma-poliglutamico y zinc.
MX2019006464A (es) Nutrientes esenciales y metodos relacionados.
MX337139B (es) Composicion de miel con l-alanil-l-glutamina.
MX2015013160A (es) Metodo y productos para mejorar la absorcion celular de farmaco y suplementos dieteticos.
PH22015000589Y1 (en) Effervescent multivitamin tablet
CN102823861A (zh) 保健食品
MX350277B (es) Celulas b. texasporus deficientes de esporulacion y metodos para inactivacion eficiente y rentable y su uso.
UA77604U (ru) Производное 1,2,4-триазола, проявляющее актопротекторную активность
UA79076U (ru) Способ профилактики и лечения хронического катарального гингивита у детей с сопутствующим хроническим гастродуоденитом
UA61925U (ru) 8-МЕТИЛ-n-ХЛОРОФЕНОКСИМЕТИЛ-2,3-ДИГИДРОТИАЗОЛО[3,2-f]КСАНТИН, КОТОРЫЙ ПРОЯВЛЯЕТ ДИУРЕТИЧЕСКОЕ ДЕЙСТВИЕ
GB201209629D0 (en) Freasy tabs
UA73325U (ru) Таблетки на основе экстракта эхинацеи пурпурной

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13805547

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13805547

Country of ref document: EP

Kind code of ref document: A2